Parkinson's disease (PD) is the second most common neurodegenerative disorder. Androst-5-ene-3β, 17β-diol (ADIOL), an estrogen receptor (ER) β agonist, was found to induce a transrepressive mechanism, which selectively amend the extent of neuroinflammation and, in turn, neurodegeneration; nevertheless, its effect on PD has not yet been revealed. In consequence, our study was designed to examine the possible neuroprotective effect of ADIOL against a rotenone (ROT)-induced PD in rats. Reduction in the nuclear factor-kappa B (NF-κB) levels and the expression of down-stream inflammatory mediators was detected in the SN upon pre-treatment with ADIOL at the dose of 0.35 mg/kg/day. Likewise, light microscopy (LM) examination showed improvement in the number of viable neurons in the SN pars compacta (SNpc). In conclusion,the current study confirmed the ability of ADIOL to reduce neuroinflammation and, in turn, neurodegeneration process as well as motor impairment in PD.
Salama, R. (2016). INVESTIGATION OF THE POSSIBLE NEUROPROTECTIVE EFFECT OF AN ESTROGEN RECEPTOR BETA AGONIST AGAINST ROTENONE-INDUCED PARKINSON’S DISEASE IN RATS. Al-Azhar Journal of Pharmaceutical Sciences, 53(1), 169-180. doi: 10.21608/ajps.2016.6897
MLA
Rania Salama. "INVESTIGATION OF THE POSSIBLE NEUROPROTECTIVE EFFECT OF AN ESTROGEN RECEPTOR BETA AGONIST AGAINST ROTENONE-INDUCED PARKINSON’S DISEASE IN RATS", Al-Azhar Journal of Pharmaceutical Sciences, 53, 1, 2016, 169-180. doi: 10.21608/ajps.2016.6897
HARVARD
Salama, R. (2016). 'INVESTIGATION OF THE POSSIBLE NEUROPROTECTIVE EFFECT OF AN ESTROGEN RECEPTOR BETA AGONIST AGAINST ROTENONE-INDUCED PARKINSON’S DISEASE IN RATS', Al-Azhar Journal of Pharmaceutical Sciences, 53(1), pp. 169-180. doi: 10.21608/ajps.2016.6897
VANCOUVER
Salama, R. INVESTIGATION OF THE POSSIBLE NEUROPROTECTIVE EFFECT OF AN ESTROGEN RECEPTOR BETA AGONIST AGAINST ROTENONE-INDUCED PARKINSON’S DISEASE IN RATS. Al-Azhar Journal of Pharmaceutical Sciences, 2016; 53(1): 169-180. doi: 10.21608/ajps.2016.6897
)
View on SCiNiTO